nodes	percent_of_prediction	percent_of_DWPC	metapath
Clorazepate—GABRB2—hindbrain—Parkinson's disease	0.0163	0.0394	CbGeAlD
Clorazepate—GABRA2—hindbrain—Parkinson's disease	0.0149	0.036	CbGeAlD
Clorazepate—GABRA1—hindbrain—Parkinson's disease	0.0144	0.0348	CbGeAlD
Clorazepate—GABRA5—forebrain—Parkinson's disease	0.0119	0.0287	CbGeAlD
Clorazepate—GABRB2—brainstem—Parkinson's disease	0.00932	0.0226	CbGeAlD
Clorazepate—GABRG2—forebrain—Parkinson's disease	0.009	0.0218	CbGeAlD
Clorazepate—GABRB2—forebrain—Parkinson's disease	0.009	0.0218	CbGeAlD
Clorazepate—TSPO—embryo—Parkinson's disease	0.0086	0.0209	CbGeAlD
Clorazepate—GABRA2—brainstem—Parkinson's disease	0.00852	0.0206	CbGeAlD
Clorazepate—GABRA1—brainstem—Parkinson's disease	0.00823	0.0199	CbGeAlD
Clorazepate—GABRA2—forebrain—Parkinson's disease	0.00822	0.0199	CbGeAlD
Clorazepate—GABRA1—forebrain—Parkinson's disease	0.00794	0.0193	CbGeAlD
Clorazepate—TSPO—brainstem—Parkinson's disease	0.00788	0.0191	CbGeAlD
Clorazepate—TSPO—forebrain—Parkinson's disease	0.00761	0.0184	CbGeAlD
Clorazepate—GABRB3—forebrain—Parkinson's disease	0.00691	0.0167	CbGeAlD
Clorazepate—GABRA5—head—Parkinson's disease	0.00679	0.0165	CbGeAlD
Clorazepate—GABRB2—medulla oblongata—Parkinson's disease	0.0065	0.0158	CbGeAlD
Clorazepate—GABRG2—medulla oblongata—Parkinson's disease	0.0065	0.0158	CbGeAlD
Clorazepate—GABRA5—nervous system—Parkinson's disease	0.00644	0.0156	CbGeAlD
Clorazepate—TSPO—cardiovascular system—Parkinson's disease	0.00643	0.0156	CbGeAlD
Clorazepate—GABRA3—head—Parkinson's disease	0.00632	0.0153	CbGeAlD
Clorazepate—GABRA5—central nervous system—Parkinson's disease	0.0062	0.015	CbGeAlD
Clorazepate—GABRA3—nervous system—Parkinson's disease	0.00599	0.0145	CbGeAlD
Clorazepate—GABRB2—midbrain—Parkinson's disease	0.00594	0.0144	CbGeAlD
Clorazepate—GABRG2—midbrain—Parkinson's disease	0.00594	0.0144	CbGeAlD
Clorazepate—GABRB2—spinal cord—Parkinson's disease	0.0058	0.014	CbGeAlD
Clorazepate—GABRG2—spinal cord—Parkinson's disease	0.0058	0.014	CbGeAlD
Clorazepate—GABRA3—central nervous system—Parkinson's disease	0.00577	0.014	CbGeAlD
Clorazepate—GABRA1—medulla oblongata—Parkinson's disease	0.00574	0.0139	CbGeAlD
Clorazepate—TSPO—medulla oblongata—Parkinson's disease	0.0055	0.0133	CbGeAlD
Clorazepate—GABRA1—midbrain—Parkinson's disease	0.00525	0.0127	CbGeAlD
Clorazepate—GABRB2—head—Parkinson's disease	0.00515	0.0125	CbGeAlD
Clorazepate—GABRG2—head—Parkinson's disease	0.00515	0.0125	CbGeAlD
Clorazepate—GABRA1—spinal cord—Parkinson's disease	0.00512	0.0124	CbGeAlD
Clorazepate—TSPO—midbrain—Parkinson's disease	0.00502	0.0122	CbGeAlD
Clorazepate—GABRB3—medulla oblongata—Parkinson's disease	0.00499	0.0121	CbGeAlD
Clorazepate—GABRA5—brain—Parkinson's disease	0.00492	0.0119	CbGeAlD
Clorazepate—TSPO—spinal cord—Parkinson's disease	0.0049	0.0119	CbGeAlD
Clorazepate—GABRG2—nervous system—Parkinson's disease	0.00488	0.0118	CbGeAlD
Clorazepate—GABRB2—nervous system—Parkinson's disease	0.00488	0.0118	CbGeAlD
Clorazepate—GABRA2—head—Parkinson's disease	0.00471	0.0114	CbGeAlD
Clorazepate—GABRB2—central nervous system—Parkinson's disease	0.0047	0.0114	CbGeAlD
Clorazepate—GABRG2—central nervous system—Parkinson's disease	0.0047	0.0114	CbGeAlD
Clorazepate—GABRB2—cerebellum—Parkinson's disease	0.0046	0.0111	CbGeAlD
Clorazepate—GABRG2—cerebellum—Parkinson's disease	0.0046	0.0111	CbGeAlD
Clorazepate—GABRA3—brain—Parkinson's disease	0.00458	0.0111	CbGeAlD
Clorazepate—GABRB3—midbrain—Parkinson's disease	0.00456	0.0111	CbGeAlD
Clorazepate—GABRA1—head—Parkinson's disease	0.00455	0.011	CbGeAlD
Clorazepate—GABRA2—nervous system—Parkinson's disease	0.00446	0.0108	CbGeAlD
Clorazepate—GABRB3—spinal cord—Parkinson's disease	0.00445	0.0108	CbGeAlD
Clorazepate—TSPO—head—Parkinson's disease	0.00436	0.0106	CbGeAlD
Clorazepate—GABRA1—nervous system—Parkinson's disease	0.00431	0.0105	CbGeAlD
Clorazepate—GABRA2—central nervous system—Parkinson's disease	0.0043	0.0104	CbGeAlD
Clorazepate—GABRA2—cerebellum—Parkinson's disease	0.0042	0.0102	CbGeAlD
Clorazepate—GABRA1—central nervous system—Parkinson's disease	0.00415	0.0101	CbGeAlD
Clorazepate—TSPO—nervous system—Parkinson's disease	0.00413	0.01	CbGeAlD
Clorazepate—GABRA1—cerebellum—Parkinson's disease	0.00406	0.00984	CbGeAlD
Clorazepate—TSPO—central nervous system—Parkinson's disease	0.00398	0.00964	CbGeAlD
Clorazepate—GABRB3—head—Parkinson's disease	0.00396	0.00959	CbGeAlD
Clorazepate—TSPO—cerebellum—Parkinson's disease	0.00389	0.00942	CbGeAlD
Clorazepate—GABRB3—nervous system—Parkinson's disease	0.00375	0.00909	CbGeAlD
Clorazepate—GABRB2—brain—Parkinson's disease	0.00373	0.00905	CbGeAlD
Clorazepate—GABRG2—brain—Parkinson's disease	0.00373	0.00905	CbGeAlD
Clorazepate—GABRB3—central nervous system—Parkinson's disease	0.00361	0.00875	CbGeAlD
Clorazepate—GABRB3—cerebellum—Parkinson's disease	0.00353	0.00855	CbGeAlD
Clorazepate—GABRA2—brain—Parkinson's disease	0.00341	0.00827	CbGeAlD
Clorazepate—GABRA1—brain—Parkinson's disease	0.0033	0.00799	CbGeAlD
Clorazepate—TSPO—brain—Parkinson's disease	0.00316	0.00765	CbGeAlD
Clorazepate—GABRB3—brain—Parkinson's disease	0.00287	0.00695	CbGeAlD
Clorazepate—Bromazepam—CYP2E1—Parkinson's disease	0.0022	0.0962	CrCbGaD
Clorazepate—Clonazepam—CYP2E1—Parkinson's disease	0.00206	0.0902	CrCbGaD
Clorazepate—CYP3A4—nervous system—Parkinson's disease	0.00192	0.00465	CbGeAlD
Clorazepate—CYP3A4—central nervous system—Parkinson's disease	0.00185	0.00448	CbGeAlD
Clorazepate—Clozapine—HTR7—Parkinson's disease	0.00167	0.0728	CrCbGaD
Clorazepate—Chlordiazepoxide—CYP2D6—Parkinson's disease	0.00157	0.0686	CrCbGaD
Clorazepate—Clozapine—DRD3—Parkinson's disease	0.00157	0.0685	CrCbGaD
Clorazepate—Clozapine—DRD1—Parkinson's disease	0.00154	0.0672	CrCbGaD
Clorazepate—Nitrazepam—CYP2E1—Parkinson's disease	0.0015	0.0654	CrCbGaD
Clorazepate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00132	0.00233	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00132	0.00233	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00131	0.00232	CbGpPWpGaD
Clorazepate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00131	0.00232	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00129	0.00228	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—GRIN2B—Parkinson's disease	0.00128	0.00227	CbGpPWpGaD
Clorazepate—Clozapine—HTR1A—Parkinson's disease	0.00128	0.0558	CrCbGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00127	0.00225	CbGpPWpGaD
Clorazepate—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00126	0.00223	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00126	0.00223	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—GRIK2—Parkinson's disease	0.00126	0.00223	CbGpPWpGaD
Clorazepate—Midazolam—CYP2E1—Parkinson's disease	0.00123	0.0539	CrCbGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00123	0.00218	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00123	0.00218	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00123	0.00217	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00122	0.00216	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—GRIK2—Parkinson's disease	0.00122	0.00216	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—SLC18A2—Parkinson's disease	0.00122	0.00216	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.0012	0.00212	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—GRIK2—Parkinson's disease	0.0012	0.00212	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.0012	0.00212	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.0012	0.00212	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—SLC18A2—Parkinson's disease	0.00118	0.00209	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—GRIK1—Parkinson's disease	0.00118	0.00209	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00118	0.00209	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00118	0.00209	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—GRIK2—Parkinson's disease	0.00118	0.00209	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00118	0.00208	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00118	0.00208	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00117	0.00207	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—GRIK2—Parkinson's disease	0.00117	0.00207	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00116	0.00206	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—SLC18A2—Parkinson's disease	0.00116	0.00206	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00116	0.00205	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00116	0.00205	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00115	0.00204	CbGpPWpGaD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00115	0.00204	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00115	0.00204	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—GRIK2—Parkinson's disease	0.00115	0.00204	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00115	0.00203	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00115	0.00203	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—SLC18A2—Parkinson's disease	0.00114	0.00202	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—SLC18A2—Parkinson's disease	0.00113	0.00201	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00113	0.002	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00113	0.002	CbGpPWpGaD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00112	0.00199	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00112	0.00198	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—SLC18A2—Parkinson's disease	0.00111	0.00197	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.0011	0.00195	CbGpPWpGaD
Clorazepate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00109	0.00193	CbGpPWpGaD
Clorazepate—Clozapine—DRD2—Parkinson's disease	0.00108	0.0474	CrCbGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00108	0.00191	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00108	0.00191	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00107	0.0019	CbGpPWpGaD
Clorazepate—Diazepam—CYP2E1—Parkinson's disease	0.00106	0.0462	CrCbGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00106	0.00187	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00105	0.00187	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00105	0.00186	CbGpPWpGaD
Clorazepate—Clozapine—CYP2E1—Parkinson's disease	0.00104	0.0456	CrCbGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00104	0.00184	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00103	0.00183	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—BDNF—Parkinson's disease	0.00103	0.00182	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00103	0.00182	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00102	0.0018	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00101	0.0018	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00101	0.00179	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00101	0.00179	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00101	0.00178	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.001	0.00178	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—GRIK2—Parkinson's disease	0.001	0.00178	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000993	0.00176	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000991	0.00175	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000989	0.00175	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000985	0.00175	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000985	0.00175	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000984	0.00174	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000976	0.00173	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	0.000973	0.00172	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00097	0.00172	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000966	0.00171	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—CHRNA4—Parkinson's disease	0.000963	0.00171	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000952	0.00169	CbGpPWpGaD
Clorazepate—Clobazam—ABCB1—Parkinson's disease	0.000949	0.0415	CrCbGaD
Clorazepate—GABRA5—Neuronal System—CHRNA4—Parkinson's disease	0.000935	0.00166	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000921	0.00163	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—CHRNA4—Parkinson's disease	0.000919	0.00163	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—NGF—Parkinson's disease	0.000912	0.00162	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—CHRNA4—Parkinson's disease	0.000903	0.0016	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—CHRNA4—Parkinson's disease	0.000897	0.00159	CbGpPWpGaD
Clorazepate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000893	0.00158	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000885	0.00157	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—HSPA8—Parkinson's disease	0.000883	0.00156	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—CHRNA4—Parkinson's disease	0.000881	0.00156	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000879	0.00156	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000864	0.00153	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00086	0.00152	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—HSPA8—Parkinson's disease	0.000857	0.00152	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000857	0.00152	CbGpPWpGaD
Clorazepate—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000855	0.00152	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000854	0.00151	CbGpPWpGaD
Clorazepate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00085	0.00151	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000845	0.0015	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000845	0.0015	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—HSPA8—Parkinson's disease	0.000842	0.00149	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000839	0.00149	CbGpPWpGaD
Clorazepate—Clozapine—HTR2A—Parkinson's disease	0.000838	0.0366	CrCbGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000832	0.00147	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00083	0.00147	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—DLG4—Parkinson's disease	0.000828	0.00147	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—HSPA8—Parkinson's disease	0.000827	0.00147	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000827	0.00147	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000825	0.00146	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000825	0.00146	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000824	0.00146	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—HSPA8—Parkinson's disease	0.000822	0.00146	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000819	0.00145	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00081	0.00143	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—GRIN2B—Parkinson's disease	0.00081	0.00143	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—HSPA8—Parkinson's disease	0.000807	0.00143	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—DLG4—Parkinson's disease	0.000805	0.00143	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000804	0.00142	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—SLC6A3—Parkinson's disease	0.000798	0.00141	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—DLG4—Parkinson's disease	0.00079	0.0014	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	0.000786	0.00139	CbGpPWpGaD
Clorazepate—Nitrazepam—ABCB1—Parkinson's disease	0.000785	0.0343	CrCbGaD
Clorazepate—GABRA2—Neuronal System—DLG4—Parkinson's disease	0.000776	0.00138	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	0.000775	0.00137	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	0.000772	0.00137	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—DLG4—Parkinson's disease	0.000771	0.00137	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.00077	0.00136	CbGpPWpGaD
Clorazepate—Clozapine—CYP2D6—Parkinson's disease	0.000766	0.0335	CrCbGaD
Clorazepate—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	0.000761	0.00135	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	0.000759	0.00134	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000758	0.00134	CbGpPWpGaD
Clorazepate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000756	0.00134	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	0.000754	0.00134	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	0.000748	0.00132	CbGpPWpGaD
Clorazepate—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000746	0.00132	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	0.000743	0.00132	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.00074	0.00131	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000734	0.0013	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.00073	0.00129	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000708	0.00125	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000706	0.00125	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000703	0.00124	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000699	0.00124	CbGpPWpGaD
Clorazepate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000692	0.00123	CbGpPWpGaD
Clorazepate—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000682	0.00121	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000678	0.0012	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000674	0.00119	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000662	0.00117	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—COMT—Parkinson's disease	0.000659	0.00117	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000654	0.00116	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000654	0.00116	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000647	0.00115	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000647	0.00115	CbGpPWpGaD
Clorazepate—Midazolam—ABCB1—Parkinson's disease	0.000647	0.0283	CrCbGaD
Clorazepate—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000643	0.00114	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000638	0.00113	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000636	0.00113	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000635	0.00113	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—COMT—Parkinson's disease	0.000632	0.00112	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.000632	0.00112	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.000627	0.00111	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000624	0.00111	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—COMT—Parkinson's disease	0.00062	0.0011	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000616	0.00109	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000613	0.00109	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000613	0.00109	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000609	0.00108	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000602	0.00107	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000598	0.00106	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000585	0.00104	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000574	0.00102	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000564	0.001	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000561	0.000993	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000561	0.000993	CbGpPWpGaD
Clorazepate—Diazepam—ABCB1—Parkinson's disease	0.000554	0.0242	CrCbGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000551	0.000975	CbGpPWpGaD
Clorazepate—Clozapine—ABCB1—Parkinson's disease	0.000547	0.0239	CrCbGaD
Clorazepate—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000542	0.000961	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000538	0.000954	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000523	0.000926	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000513	0.000909	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000492	0.000871	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000485	0.000859	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000481	0.000852	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000472	0.000836	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000461	0.000817	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000438	0.000776	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000429	0.00076	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000417	0.000738	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000414	0.000734	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000413	0.000732	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000412	0.00073	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000409	0.000725	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000402	0.000712	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.0004	0.000709	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.0004	0.000708	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000393	0.000696	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000392	0.000695	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000386	0.000684	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000384	0.000679	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000377	0.000667	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000358	0.000634	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000348	0.000616	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000344	0.000609	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000343	0.000607	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000342	0.000605	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000336	0.000595	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000334	0.000591	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000333	0.000591	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000329	0.000583	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000328	0.000581	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000327	0.00058	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000326	0.000577	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000322	0.000571	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000321	0.000569	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00032	0.000567	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000314	0.000557	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000301	0.000532	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000298	0.000528	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000294	0.00052	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000286	0.000507	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000275	0.000487	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000247	0.000437	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000246	0.000435	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000245	0.000434	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000243	0.000431	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000243	0.00043	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000242	0.000429	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000226	0.0004	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000223	0.000394	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.00016	0.000283	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ND3—Parkinson's disease	0.00016	0.000283	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—OMD—Parkinson's disease	0.00015	0.000267	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.00015	0.000267	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000143	0.000253	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000136	0.000241	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000121	0.000215	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000121	0.000215	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000121	0.000215	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—DDC—Parkinson's disease	8.9e-05	0.000158	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTA4—Parkinson's disease	8.41e-05	0.000149	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	7.57e-05	0.000134	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MAOB—Parkinson's disease	7.49e-05	0.000133	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.57e-05	9.86e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.47e-05	9.68e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.09e-05	9.02e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.04e-05	8.92e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TH—Parkinson's disease	4.96e-05	8.79e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.77e-05	8.44e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—COMT—Parkinson's disease	4.22e-05	7.48e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.2e-05	7.44e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.19e-05	7.42e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.14e-05	7.34e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.98e-05	7.04e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.86e-05	6.84e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.7e-05	6.55e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.41e-05	6.04e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—APOE—Parkinson's disease	3.18e-05	5.63e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—INS—Parkinson's disease	2.71e-05	4.81e-05	CbGpPWpGaD
